Stonington, CT, United States of America

Mark A Guadliana


Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Gales Ferry, CT (US) (1983)
  • Stonington, CT (US) (1996 - 2002)

Company Filing History:


Years Active: 1983-2002

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mark A. Guadliana

Introduction

Mark A. Guadliana is a notable inventor based in Stonington, Connecticut. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of gastroduodenal diseases. With a total of six patents to his name, Guadliana's work has the potential to impact many lives.

Latest Patents

Among his latest patents is a groundbreaking compound for treating gastroduodenal diseases, known as Spirolaxine. This compound, represented by the formula (I) wherein R is H, along with novel compounds where R is (C-C) alkyl or CH(CH)CO, is designed to address conditions such as gastric ulcers, duodenal ulcers, and gastric cancer. Spirolaxine and its methyl ether are isolated from the fermentation of ATCC 74278. Additionally, these compounds can be used in combination with H antagonists, colloidal bismuth subcitrate, and other antibiotics, showcasing their versatility in treatment.

Career Highlights

Guadliana's career is marked by his dedication to pharmaceutical innovation. His work at Pfizer Corporation has allowed him to focus on developing effective treatments for complex medical conditions. His patents reflect a commitment to advancing medical science and improving patient outcomes.

Collaborations

Throughout his career, Guadliana has collaborated with esteemed colleagues, including Liang H. Huang and Takushi Kaneko. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Mark A. Guadliana's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare. His work continues to pave the way for new treatments that can significantly benefit patients suffering from gastroduodenal diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…